Ionis gains approval of zilganersen for Alexander disease (NASDAQ:IONS)
· seekingalpha.com
The US FDA on Thursday approved Ionis' Zanvastro (zilganersen) as the first-ever treatment for Alexander disease. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...